O12 FOLFOXIRI versus FOLFIRI as first line treatment in metastatic colorectal cancer (MCC): a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)
Titel:
O12 FOLFOXIRI versus FOLFIRI as first line treatment in metastatic colorectal cancer (MCC): a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)
Auteur:
Vamvakas, L. Androulakis, N. Syrigos, K. Polyzos, A. Ziras, N. Athanasiadis, A. Kakolyris, S. Tsousis, S. Kouroussis, Ch. Kalykaki, A. Samonis, G. Mavroudis, D. Georgoulias, V. Souglakos, J.